February 2014


Mitodys Logo Canvas



MitoDys is a drug-discovery platform, working on a novel approach to treating Parkinson's disease.

MitoDys is headed up by founder Steven Zimmer and a world-class board of scientific and clinical advisors led by Dr David Weiner, a clinician scientist who is a noted expert in Parkinson’s disease, along with a network of academic laboratories and partner CROs.


Mito Dys Theraputics Canvas


How Much?

MitoDys hit their target and raised £150,000


Who invested?

The Life Neurological Research Trust, two business angels and SyndicateRoom members.



To fund the initial optimisation and validation of MitoDys’ discovery platform through initial drug prototypes.

Take a look at MitoDys website to find out the latest news: www.mitodys.com